Racial and ethnic and income disparities in COVID-19 vaccination among Medicare beneficiaries

J Am Geriatr Soc. 2022 Sep;70(9):2638-2645. doi: 10.1111/jgs.17920. Epub 2022 Jun 7.

Abstract

Background: Older adults have been disproportionately affected by the COVID-19 pandemic. Despite the widespread availability and proved effectiveness of COVID-19 vaccines, the issue of inequity in vaccine uptake in the United States is a potential concern among different populations. This study examined racial and ethnic and income disparities in COVID-19 vaccination rate among Medicare beneficiaries.

Methods: Data from the Medicare Current Beneficiary Survey (MCBS) COVID-19 Winter 2021 Community Supplement were employed (n = 9606 Medicare beneficiaries, weighted N = 50,512,963). We fitted a logistic regression model to determine the association of vaccination status with beneficiary race and ethnicity and income, after controlled for a set of beneficiary characteristics.

Results: Compared with non-Hispanic White respondents, Hispanic respondents (OR = 0.72, 95% CI: 0.54-0.96, p = 0.02) and Black respondents (OR = 0.84, 95% CI: 0.67-1.04, p = 0.11) were less likely to receive COVID-19 vaccine. In addition, the likelihood of COVID-19 vaccine uptake for beneficiaries who earn less than $25,000 per year was more than 50% lower than that for those whose annual income was $25,000 or more (OR = 0.44, 95% CI: 0.37-0.53, p < 0.0001).

Conclusions: Racial and ethnic and income disparities exist in COVID-19 vaccination rate among Medicare beneficiaries nationally. Community-based strategies to boost vaccine uptake may target racial and ethnic minorities and socioeconomically disadvantaged groups to reduce such disparities.

Keywords: COVID-19 vaccination; Medicare current beneficiary survey; income disparities; older adults; race and ethnicity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Ethnicity*
  • Humans
  • Medicare
  • Pandemics
  • United States / epidemiology
  • Vaccination

Substances

  • COVID-19 Vaccines